Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.

Keiser P, Nassar N, Skiest D, Andrews C, Yazdani B, White A, Hetherington S.

Int J STD AIDS. 2003 Jul;14(7):478-81.

PMID:
12869229
2.

[Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele].

Pérez Prior N, Rocher Milla A, Soler Company E, Flores Cid J, Sarria Chust B.

Farm Hosp. 2009 May-Jun;33(3):155-60. Spanish.

PMID:
19712599
3.

Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report.

Lanzafame M, Trevenzoli M, Lattuada E, Faggian F, Vento S, Concia E.

Infez Med. 2003 Mar;11(1):40-1.

4.

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.

Hetherington S, McGuirk S, Powell G, Cutrell A, Naderer O, Spreen B, Lafon S, Pearce G, Steel H.

Clin Ther. 2001 Oct;23(10):1603-14.

PMID:
11726000
5.

Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction.

[No authors listed]

AIDS Treat News. 2000 Feb 18;(No 337):7-8.

PMID:
11367210
6.

Risk factor analysis of hypersensitivity reactions to abacavir.

Symonds W, Cutrell A, Edwards M, Steel H, Spreen B, Powell G, McGuirk S, Hetherington S.

Clin Ther. 2002 Apr;24(4):565-73.

PMID:
12017401
7.

Epidemiological risk factors for hypersensitivity reactions to abacavir.

Easterbrook PJ, Waters A, Murad S, Ives N, Taylor C, King D, Vyakarnam A, Thorburn D.

HIV Med. 2003 Oct;4(4):321-4.

8.

Abacavir hypersensitivity reaction in primary HIV infection.

Stekler J, Maenza J, Stevens C, Holte S, Malhotra U, McElrath MJ, Corey L, Collier AC.

AIDS. 2006 Jun 12;20(9):1269-74.

PMID:
16816555
9.

Hypersensitivity reactions due to abacavir.

[No authors listed]

Newsline People AIDS Coalit N Y. 1998 Feb:35-6.

PMID:
11367446
10.

Abacavir hypersensitivity reaction: an update.

Hughes CA, Foisy MM, Dewhurst N, Higgins N, Robinson L, Kelly DV, Lechelt KE.

Ann Pharmacother. 2008 Mar;42(3):387-96. doi: 10.1345/aph.1K522. Epub 2008 Feb 26. Review.

PMID:
18303141
11.

HLA-B*5701 screening for hypersensitivity to abacavir.

Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team.

N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135.

12.

Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.

Giorgini S, Martinelli C, Tognetti L, Carocci A, Giuntini R, Mastronardi V, Torricelli F, Leoncini F, Lotti T.

Dermatol Ther. 2011 Nov-Dec;24(6):591-4. doi: 10.1111/j.1529-8019.2012.01409.x.

PMID:
22515676
13.

Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir.

Cutrell AG, Hernandez JE, Fleming JW, Edwards MT, Moore MA, Brothers CH, Scott TR.

Ann Pharmacother. 2004 Dec;38(12):2171-2. Epub 2004 Nov 9. No abstract available.

PMID:
15536137
14.

Detection of abacavir hypersensitivity by ELISpot method.

Esser S, Jablonka R, Heinemann FM, Reuter S, Jaeger H, von Krosigk A, Schenk-Westkamp P, Schadendorf D, Horn PA, Lindemann M.

Inflamm Allergy Drug Targets. 2012 Jun;11(3):227-34.

PMID:
22338581
15.

Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir.

Phillips EJ, Sullivan JR, Knowles SR, Shear NH.

AIDS. 2002 Nov 8;16(16):2223-5. No abstract available.

PMID:
12409746
16.

Incidence of abacavir hypersensitivity reactions in euroSIDA.

Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

Antivir Ther. 2008;13(5):687-96.

PMID:
18771052
17.

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.

Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, Mallal S.

Clin Infect Dis. 2006 Jul 1;43(1):99-102. Epub 2006 May 26.

PMID:
16758424
18.

Identification of abacavir hypersensitivity reaction in health care claims data.

Nordstrom BL, Norman HS, Dube TJ, Wilcox MA, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):289-96.

PMID:
17245797
19.

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, Lai E, Davies K, Handley A, Dow DJ, Fling ME, Stocum M, Bowman C, Thurmond LM, Roses AD.

Lancet. 2002 Mar 30;359(9312):1121-2.

PMID:
11943262
20.

1592 (abacavir): do not rechallenge after hypersensitivity reaction.

James JS.

AIDS Treat News. 1997 Dec 19;(No 285):1, 5.

PMID:
11364916

Supplemental Content

Support Center